To further validate the relationship between ODF2L and the response to WEE1 inhibition in EOC, we examined the correlation of ODF2L levels, CDK1 activity, and cell viability in a panel of AZD1775-treated primary EOC cells derived from 57 tissue samples from patients with ovarian cancer (Supplemental Table 2). This evidence concerns the gene ODF2L and ovarian cancer.